JPMorgan Chase & Co. 13D and 13G filings for Sionna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-30 1:19 pm Purchase |
2025-06-30 | 13G | Sionna Therapeutics, Inc. SION |
JPMORGAN CHASE & CO JPM |
2,221,188 5.000% |
2,221,188 (New Position) |
Filing |